⌘K
Loading ticker…
Onconetix, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Onconetix, Inc. Common Stock (ONCO) has a 3-month relative strength percentile of 1 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 19. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 10.0%, relative volume 0.18×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
1 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ONCO is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -69.6% / -98.7%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ONCO Jan avg: -8.69% median: -8.97% win: 0% σ: 5.07% n: 3 2023-12-26 → 2026-05-29 | ONCO Feb avg: -39.31% median: -52.89% win: 0% σ: 24.95% n: 3 2023-12-26 → 2026-05-29 | ONCO Mar avg: -44.62% median: -55.46% win: 0% σ: 30.73% n: 3 2023-12-26 → 2026-05-29 | ONCO Apr avg: -27.88% median: -23.96% win: 0% σ: 23.80% n: 3 2023-12-26 → 2026-05-29 | ONCO May avg: 51.89% median: 72.79% win: 100% σ: 39.17% n: 3 2023-12-26 → 2026-05-29 | ONCO Jun avg: -23.50% median: -23.50% win: 0% σ: 6.44% n: 2 2023-12-26 → 2026-05-29 (current) | ONCO Jul avg: -16.33% median: -16.33% win: 0% σ: 12.78% n: 2 2023-12-26 → 2026-05-29 | ONCO Aug avg: -15.04% median: -15.04% win: 0% σ: 3.75% n: 2 2023-12-26 → 2026-05-29 | ONCO Sep avg: 0.94% median: 0.94% win: 50% σ: 7.36% n: 2 2023-12-26 → 2026-05-29 | ONCO Oct avg: -17.71% median: -17.71% win: 50% σ: 37.78% n: 2 2023-12-26 → 2026-05-29 | ONCO Nov avg: -47.06% median: -47.06% win: 0% σ: 41.10% n: 2 2023-12-26 → 2026-05-29 | ONCO Dec avg: -16.12% median: -8.70% win: 33% σ: 24.89% n: 3 2023-12-26 → 2026-05-29 |